A desire to create a home for creative exploration of practice and research is what spurred Anne to found Remedy. Anne works primarily from cognitive-behavioural and mindfulness-based approaches, helping individuals, couples, and other intimate relationship constellations navigate trauma, depression, life stressors, relationship stressors and enhancement, growth, and exploration, as well as preparation and integration of psychedelic and non-ordinary state of consciousness experiences. Anne facilitates Mindfulness-Based Cognitive Therapy, since she believes in the value of staying with experiences, and paying attention to the moment with curiosity and without judgment. Anne strongly believes in the fit between therapist and client, and strives to be genuine, empathic, honest, curious, and warm as a therapist. Her practice is honouring and inclusive of all sexual and gender identities and expressions. She holds the principles of inclusivity, trauma-competency, anti-oppression, and feminism dear.
Anne is one of the investigators of Cognitive-Behavioral Conjoint Therapy for PTSD + MDMA, a Multidisciplinary Association for Psychedelic Studies (MAPS) sponsored trial. She will be leading the MAPS funded trial of Cognitive Processing Therapy (CPT) for PTSD + MDMA. Anne has done extensive work with communities impacted by HIV, and collaborates on projects with LGBTQ and AIDS service organizations (ASOs) on trauma-informed care and trauma treatment. Anne trains and supervises students in evidence-based PTSD treatment and couples therapy, and provides consultation and training to other providers learning these treatments. Anne sits on the Quality Committee of Casey House, Toronto’s HIV/AIDS hospital, and is the Chair of the Traumatic Stress Section of the Canadian Psychological Association.
Academic Appointment – Adjunct Professor, Faculty of Arts, and Associate Member, Yeates School of Graduate Studies, Ryerson University
Fellowship – Canadian Institutes of Health Research, Ryerson University
Residency – Centre for Addiction and Mental Health, Toronto, Canada
Ph.D. – Clinical Psychology, Ryerson University
Toronto, ON, Canada – March 7th, 2020 – Science Meets Psychedelics – Great Conversations, Ontario Science Centre Speaker Series.
Toronto, ON, Canada – April 3rd, 2020 – The Future of Psychedelic-Assisted Psychotherapy, Remedy.
Montreal, QC, Canada – May 28th – 30th, 2020 – Clinical Sections Invited Speaker, Canadian Psychological Association.
Vancouver, BC, Canada – December 14th, 2019 – Women in Psychedelic Science, MAPS Canada.
Boston, MA, USA – November 14th-16th, 2019 – International Society of Traumatic Stress Studies Annual Conference.
New Orleans, LA, USA – October 18th-20th, 2019 – International Society for Research on Psychedelics.
Stockholm, Sweden – October 7th, 2019 – Karolinska Institute.
Helsinki, Finland – October 5th, 2019 – MDMA-avusteinen psykoterapia – miksi? | MDMA-assisted psychotherapy – why?, Psykedeelinäkymiä.
Toronto, ON, Canada – September 21st, 2019 – Mapping the Mind: Psychedelic Science Conference.
Halifax, NS, Canada – May 31st-June 2nd, 2019 – Canadian Psychological Association Annual Conference.
Piscataway, NJ, USA – April 11th, 2019 – Emerging Addiction Science Seminar, Rutgers University.
Toronto, Canada – February 17th, 2019 – Toronto MAPS Canada Fundraiser, The Toronto Psychedelic Society.
Toronto, Canada – February 14th, 2019 – The Intersection of HIV Stigma and Trauma-Informed Practice, Casey House: HIV & Mental Health Series, in collaboration with St. Michael’s Hospital.
Toronto, Canada – January 29th, 2019 – Mental Health Innovation, PTSD, MDMA and More, The Redefining Reality Podcast with Bryan Hardy
Toronto, Canada – November 14th, 2018 – Better Than TED: Talking HIV Research, Casey House.
Washington, DC, USA – November 8th-10th, 2018 – International Society of Traumatic Stress Studies Annual Conference.
Toronto, Canada – November 2nd, 2018 – Centre for Clinical Ethicists Annual Conference, St. Michael’s Hospital.
Toronto, Canada – October 24th, 2018 – Leaf Forward Panel, “The Future of Drugs”.
Stockholm, Sweden – October 13th-14th, 2018 – Nordic Colloquium on Psychedelic Psychiatry.
Toronto, Canada – September 22nd, 2018 – Mapping the Mind with Mushrooms, University of Toronto.
Selected Recent Publications
Wagner, A.C., Mithoefer, M.C., & Monson, C.M. (2019). Breaking the mold: Reflecting on our experiences in same-gender therapist teams with MDMA-assisted psychotherapy. MAPS Bulletin Spring 2019, 29(1).
Wagner, A.C., Mithoefer, M.C., Mithoefer, A.T., & Monson, C.M. (2019). Combining Cognitive-Behavioral Conjoint Therapy for PTSD with 3,4-methylenedioxymethamphetamine (MDMA): A case example. Journal of Psychoactive Drugs. doi: 10.1080/02791072.2019.1589028
Wagner, A.C., Mithoefer, M.C., & Doblin, R. (2019). Bringing Psychedelics into Mainstream Pharmaceuticals. In M. Winkelman & B. Sessa (Eds.), Advances in Psychedelic Medicine: State-of-the-Art Therapeutic Applications. Santa Barbara, CA: ABC-Clio Inc.
Wagner, A.C., Landy, M.S.H., & Monson, C.M. (2019). Cognitive-Behavioral Conjoint Therapy for PTSD: Theory and Practice of Couple and Family Interventions for PTSD. In B. Moore & W. Penk (Eds.), Treating PTSD in Military Personnel: A Clinical Handbook, 2nd Edition. Guilford Press.
Wagner, A.C., Jaworsky, D., Logie, C.H., Conway, T., Pick, N., Wozniak, D., Rana, J., Tharao, W., Kaida, A., de Pokomandy, A., Ion, A., Chambers, L.A., Webster, K., MacGillivray, S.J., Loutfy, M., on behalf of the CHIWOS Research Team. (2018). High rates of posttraumatic stress symptoms in women living with HIV in Canada. Plos One.
Wagner, A.C., Girard, T., McShane, K.E., Margolese, S., & Hart, T.A. (2017). HIV-related stigma and overlapping stigmas towards people living with HIV among health care trainees in Canada. AIDS Education and Prevention, 29, 364-376. doi: 10.1521/aeap.2017.29.4.364
Monson, C.M., Wagner, A.C., Fredman, S.J., Macdonald, A., & Pukay-Martin, N.D. (2017). Couple and family therapy for traumatic stress conditions. In J. Cook, S. Gold, & C. Dalenberg (Eds.), APA Handbook of Trauma Psychology. Washington, DC: APA.
Logie, C., Lacombe-Duncan, A., Poteat, T., & Wagner, A.C. (2017). Syndemic factors mediate the relationship between sexual stigma and depression among sexual minority women and gender minorities. Women’s Health Issues, 27, 592-599. doi: 10.1016/j.whi.2017.05.003
Wagner, A.C., Torbit, L., Jenzer, T., Landy, M.S.H., Pukay-Martin, N.D., Macdonald, A., Fredman, S.J., & Monson, C.M. (2016). The role of posttraumatic growth in a randomized controlled trial of cognitive-behavioral conjoint therapy for PTSD. Journal of Traumatic Stress, 29, 379-383. doi: 10.1002/jts.22122
Wagner, A.C., Monson, C.M., & Hart, T.L. (2016). Understanding social factors in the context of trauma: Implications for measurement and intervention. Journal of Aggression, Maltreatment and Trauma, 25, 831-853. doi: 10.1080/10926771.2016.1152341
Wagner, A.C., McShane, K.E., Hart, T.A., & Margolese, S. (2016). A focus group qualitative study of HIV stigma in the Canadian healthcare system. Canadian Journal of Human Sexuality, 25, 61-71. doi: 10.3138/cjhs.251-A6
Ion, A., Wagner, A.C., Greene, S., & Loutfy, M.R. for the HIV Mothering Study. (2016). HIV-related stigma in pregnancy and early postpartum of mothers living with HIV in Ontario, Canada. AIDS Care, 29, 137-144. doi: 10.1080/09540121.2016.1211608
Wagner, A.C., Hart, T.A., McShane, K.E., Margolese, S., & Girard, T.A. (2014). Health care provider attitudes and beliefs about people living with HIV: Initial validation of the Health Care Provider HIV/AIDS Stigma Scale (HPASS). AIDS and Behavior, 18, 2397-2408. doi: 10.1007/s10461-014-0834-8